Scholar Rock Holding (SRRK) Other Operating Expenses (2024 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Other Operating Expenses of -$3000.0 in Q1 2026, up 99.98% quarter-over-quarter from -$12.8 million in Q4 2025, and up 99.97% on a YoY basis from -$1500.3 in Q1 2025.
Scholar Rock Holding (SRRK) Other Operating Expenses (2024 - 2026) Analysis & Trends
Scholar Rock Holding's Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$3000.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 99.97% year-over-year to -$3000.0; the TTM figure through Mar 2026 stood at -$47.1 million (down 79.08% YoY), while the FY2025 annual figure was -$56.1 million, down 150.55% from the prior year.
- Other Operating Expenses was -$3000.0 for Q1 2026 at Scholar Rock Holding, up from -$12.8 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of -$3000.0 in Q1 2026 to a low of -$19.4 million in Q3 2025.
- Historically, Other Operating Expenses has averaged -$8.7 million across 3 years, with a median of -$6.2 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Other Operating Expenses tumbled 281.56% in 2025, then jumped 99.97% in 2026.
- A 3-year view of Other Operating Expenses shows it stood at -$6.2 million in 2024, then plunged by 106.96% to -$12.8 million in 2025, then soared by 99.98% to -$3000.0 in 2026.
- The last three Other Operating Expenses figures came in at -$3000.0 (Q1 2026), -$12.8 million (Q4 2025), and -$19.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -12.76 Mn |
| Sep 30, 2025 | -19.43 Mn |
| Jun 30, 2025 | -14.95 Mn |
| Mar 31, 2025 | -8.94 Mn |
| Dec 31, 2024 | -6.16 Mn |
| Sep 30, 2024 | -5.09 Mn |
| Jun 30, 2024 | -6.13 Mn |
| Mar 31, 2024 | -5.00 Mn |